Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
p acnes corneal ulcer endopthalmitis kaposi esotropia intraocular uveitis optic neuritis anisocoria retinitisYour Article Summary
Multiple sclerosis. Part I: Neuro-ophthalmic manifestations
Current Opinion in Ophthalmology, 10/29/09
Pula JH et al. – Multiple sclerosis results in various ophthalmic abnormalities. Optic neuritis is the most widely studied visual disturbance in MS, but other unusual visual manifestations such as Charles Bonnet syndrome or the Pulfrich phenomenon also occur. OCT is used to measure thickness of the retinal nerve fiber layer. Because thinning of this layer in MS represents axonal loss, OCT is being used to evaluate neuroprotective treatments. The efferent visual system, in particular the medial longitudinal fasciculus pathway, may be a way to measure body temperature–induced changes in MS.
Today in Low Vision...keeping you current
Receive free subspecialty "5-minute updates" via email
Vitamin C supplements and the risk of age-related cataract: a population-based prospective cohort study in women
American Journal of Clinical Nutrition, 11/20/09
Incidence and Factors Related to Macular Hole Reopening
American Journal of Ophthalmology, 10/29/09
Comparison of the AcrySof SA60 spherical intraocular lens and the AcrySof Toric SN60T3 intraocular lens outcomes in patients with low amounts of corneal astigmatism
Clinical and Experimental Ophthalmology, 11/03/09
Today in Neuro-Ophthalmology...keeping you current
Receive free subspecialty "5-minute updates" via email
Surgical interventions for idiopathic intracranial hypertension
Current Opinion in Ophthalmology, 10/28/09
Headache and the eye
Current Opinion in Ophthalmology, 10/19/09
A retrospective study on the efficacy of total absorbed orbital doses of 12, 16 and 20 Gy combined with systemic steroid treatment in patients with Graves orbitopathy
Graefe's Archive for Clinical and Experimental Ophthalmology, 11/02/09
Article Search
Sponsor


See Latest Articles


